 |
|
A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney
Hyunjin Ryu, Eunjeong Kang, Seokwoo Park, Sehoon Park, Kyoungbun Lee, Kwon Wook Joo, Hajeong Lee
Kidney Res Clin Pract. 2015;34(4):237-240. Published online 2015 Jul 7 DOI: https://doi.org/10.1016/j.krcp.2015.06.001
|
|
Citations to this article as recorded by
 RNA Nanotechnology for Codelivering High-Payload Nucleoside Analogs to Cancer with a Synergetic Effect
Xin Li, Kai Jin, You-Cheng Liao, Wen-Jui Lee, Li-Ching Chen, Tzu-chun Cheng, Yuan-Soon Ho, Peixuan Guo
Molecular Pharmaceutics.2024; 21(11): 5690. CrossRef Chemotherapy-Associated Thrombotic Microangiopathy
Abinet M. Aklilu, Anushree C. Shirali
Kidney360.2023; 4(3): 409. CrossRef Impurity Linked Genotoxicity assessment of the Antineoplastic Chemotherapy agent using Ames model
Samrat Debnath, Subhashis Debnath, Himanta Biswa Saikia, Hadiuz Zaman, Pranabesh Sikdar
Research Journal of Pharmacy and Technology.2023; : 3339. CrossRef A Case of Gemcitabine-Induced Thrombotic Microangiopathy Treated With Ravulizumab in a Patient With Stage IV Pancreatic Cancer
Kira N MacDougall, Benjamin Schwartz, Janine Harewood, Zaheer Bukhari, Elvira Neculiseanu
Cureus.2021;[Epub] CrossRef Microangiopathie thrombotique et cancer
Rania Kheder El-Fekih, Clément Deltombe, Hassan Izzedine
Néphrologie & Thérapeutique.2017; 13(6): 439. CrossRef Microangiopathie thrombotique secondaire à la gemcitabine : peut-on améliorer le dépistage et la prise en charge ?
Xavier Charmetant, Anne Jolivot, Thomas Fournier, Jean-Charles Puthet, Philippe Cassier, Sandrine Lemoine, Laurent Juillard
Néphrologie & Thérapeutique.2017; 13(4): 251. CrossRef Antineoplastic Treatment and Renal Injury: An Update on Renal Pathology Due to Cytotoxic and Targeted Therapies
Megan L. Troxell, John P. Higgins, Neeraja Kambham
Advances in Anatomic Pathology.2016; 23(5): 310. CrossRef Cisplatin/gemcitabine
Reactions Weekly.2016; 1597(1): 65. CrossRef
|